Grünenthal has the responsibility to conduct its business and research activities in a legal and ethical manner. Building trust through the way we work gives confidence to all of our stakeholders, including patients, business partners, customers and the communities we serve.
Our compliance system provides a clear framework for our decisions and actions. It is built around our Code of Conduct. All employees are required to adhere to the principles it sets out and contribute to fulfilling our corporate responsibility.
Code of Conduct:
The Code of Conduct states our commitment to high ethical standards. It applies to all Grünenthal employees, wherever they are in the world. Everybody in our organisation has the responsibility to live up to this framework in their daily work.
Code of Conduct for Grünenthal’s Business Partners:
Grünenthal is committed to conducting its global business in compliance with all applicable laws and regulations. We treat others fairly, with respect and integrity.
Our business partners are expected to act in the same manner. Our Code of Conduct for Business Partners is intended to establish a common understanding about how to do business.
Building a culture of compliance also means building a culture of trust. We depend on our employees – and also on third parties – to raise any concerns they might have. We encourage you to report any questions, doubts or suspicions you have concerning behaviour that is not in line with our Code of Conduct or applicable laws and regulations. You can do this through our Ethics Helpline: an internet-based platform that allows you 24/7 anonymous or personal reporting.
Contact:For any further questions please contact: IECompliance@grunenthal.com
Disclosure in Ireland
The Irish Pharmaceutical Healthcare Association (IPHA) has stipulated in its Code of Practice for the Pharmaceutical Industry that member companies disclose their data in a central report hosted by IPHA: www.transferofvalue.ie.
Information regarding the disclosure of transfers of value in Ireland can be accessed directly from the IPHA website: please click here.
Support provided to patient organisations is not disclosed within the central report. To see details of the support provided by Grünenthal to patient organisations and other groups in our local community, please click here.
Date of Preparation: March 2017 IRE/G17 0005